Vivesto
0,257 SEK +1,18%2 investorer følger denne virksomhed
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VIVE
Daglig lav / høj pris
0,25 / 0,26
SEK
Markedsværdi
138,28 mio. SEK
Aktieomsætning
47,33 t SEK
Volumen
187 t
Seneste videoer
Finanskalender
Delårsrapport
21.11.2024
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Per Arwidsson med bolag | 24,8 % | 24,8 % |
| Avanza Pension | 5,8 % | 5,8 % |
| Ilija Batljan | 1,8 % | 1,8 % |
| Johan Zetterstedt | 1,5 % | 1,5 % |
| Swedbank Försäkring | 1,5 % | 1,5 % |
| Nordnet Pensionsförsäkring AB | 1,1 % | 1,1 % |
| Mastan AB (Håkan Lagerberg) | 1,0 % | 1,0 % |
| Philip Du Rietz | 0,9 % | 0,9 % |
| Jerry Wiström | 0,9 % | 0,9 % |
| Christer Ericson | 0,7 % | 0,7 % |
ViserAlle indholdstyper
Report from Annual General Meeting in Vivesto AB
Notice of Annual General Meeting in Vivesto AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools